Manipur HC: State Establishments Must Record Transgender Person’s New Name & Gender in Documents  ||  Delhi HC: Failure to Frame Counter Claim Despite Pleadings is Patently Illegal  ||  Mumbai Commission Holds Reliance Retail Liable for Defective AC Replacement Failure  ||  SC Orders ASI to Supervise Repair of Mehrauli’s Ancient Dargahs  ||  SC Reprimands Bihar IPS Officer for Affidavit Supporting Murder Convict  ||  SC Rejects Review Plea on WB SSC Jobs, Upholds Quashing of 25k Appointments  ||  SC Rejects Review Plea on WB SSC Jobs, Upholds Quashing of 25k Appointments  ||  Supreme Court Orders Haridwar Collector Inquiry into Maa Chandi Devi Trust  ||  SC Recommends Statutory Appeal Against DJ’s Compensation Orders  ||  SC Dismisses Petition Challenging 2024 Maharashtra Assembly Elections Over Bogus Voting    

Japan's Mitsubishi Pharma Corporation Loses Patent Bid over Diabetes Drug “Teneligliptin” - (14 Dec 2015)

Kolkata Patent Office on an opposition filed by domestic drug firm Lupin, refused the patent application filed by Japan's Mitsubishi Pharma Corporation claiming monopoly rights on a new diabetes drug, teneligliptin, on grounds that it was "obvious, and lacking inventive step".

Tags : KOLKATA PATENT OFFICE   PATENT   DIABETES DRUG TENELIGLIPTIN  

Share :        

Disclaimer | Copyright 2025 - All Rights Reserved